EnvÃa por correo este artÃculo 
Enviar un comentario 
Para entender la COVID-19
Resumen
Introducción: el SARS-CoV-2 fue aislado recientemente de células epiteliales de la vÃa aérea humana (enero de 2020). Este virus ha causado una pandemia que desafÃa la infraestructura de la salud pública mundial.
Objetivo: revisar la bibliografÃa disponible sobre el COVID-19.
Métodos: se realizó una búsqueda sistemática de publicaciones en las bases de datos Medline y PubMed; se utilizaron las siguientes palabras claves: COVID-19, COVID-2019, 2019-nCoV, SARS-CoV-2, 2019nCoV, Wuhan, y coronavirus.
Conclusiones: se seleccionaron 42 publicaciones que fueron trascendentes para entender las caracterÃsticas patogénicas del COVID-19 en el contexto de la pandemia decretada por la Organización Mundial de la Salud.
Palabras clave
Citas
Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019;17:181-92.
Drosten C, Gunther S, Preiser W, et al. Identifi¬cation of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-76.
Bogoch, A. Watts, A. Thomas-Bachli, C. Huber, M.U.G. Kraemer, K. Khan, Pneumonia of unknown etiology in wuhan, China: potential for international spread via commercial air travel, J. Trav. Med. (2020), https://doi.org/10.1093/jtm/ taaa008.
H. Lu, C.W. Stratton, Y.W. Tang, Outbreak of pneumonia of unknown etiology in wuhan China: the mystery and the miracle, J. Med. Virol. 92 (4) (2020) 401–402, https://doi.org/10.1002/jmv.25678.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus inWuhan. China Lancet 2020. https://doi.org/10.1016/ s0140-6736(20)30183-5.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2001316.
CDC. 2019 Novel coronavirus, Wuhan, China. 2020. https://www.cdc.gov/ coronavirus/2019-nCoV/summary.html. Accessed 1 Feb 2020.
WHO. Novel Coronavirus–China. 2020. https://www.who.int/csr/don/12- january-2020-novel-coronavirus-china/en/. Accessed 1 Feb 2020.
Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 2020 Feb 17. https: //doi.org/10.1016/j.ijantimicag.2020.105924.
S.R. Weiss, J.L. Leibowitz, Coronavirus pathogenesis, Adv. Virus Res. 81 (2011) 85–164.
U.B.R. Balasuriya, et al., List of contributors, in: N.J. MacLachlan, E.J. Dubovi (Eds.), Fenner’s Veterinary Virology, fifth ed., Academic Press, Boston, 2017, pp. xvii–xviii.
Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016;24:490-502.
N. Zhu, et al., A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med, 2020.
D. Isaacs, et al., Epidemiology of coronavirus respiratory infections, Arch. Dis. Child. 58 (7) (1983) 500–503.
S.B. Greenberg, Update on human rhinovirus and coronavirus infections, Semin. Respir. Crit. Care Med. 37 (4) (2016) 555–571.
Zhu N, Zhang DY, Wang WL et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. https ://doi.org/10.1056/ nejmo a2001 017.
Huang CL, Wang YM, Li XW et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. https :// doi.org/10.1016/s0140 -6736(20)30183 -5.
New features of novel coronavirus (2019-nCoV) pneumonia. https ://new. qq.com/omn/20200 128/20200 128A0 7H4S0 0.html. Accessed 30 Jan 2020.
Novel coronavirus (2019-nCoV) situation Report-7 http://www.who.int/ docs/defau lt-sourc e/coron aviru s/situa tion-repor t/20200 127-sitre p-7- 2019–ncov.pdf?sfvrs n=98ef7 9f5_2. Accessed 27 Jan 2020).
World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003, https://www.who.int/csr/sars/country/ table2004_04_21/en/; 2004 [accessed 2020-2-5].
World Health Organization. Middle East respiratory syndrome coronavirus (MERSCoV) https://www.who.int/emergencies/mers-cov/en/; 2013 [accessed 2020-2-5].
Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012;367:1814-20.
Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology.2003;8:S9–14.
Middle East Respiratory Syndrome Coronavirus. Available at: https://www.who.int/emergencies/mers-cov/en/. Accessed 16 Feb 2020.
Huanan Seafood Wholesale Market. In: Wikipedia [Internet]. 2020 [cited 2020 Apr 12]. Available from: https://en.wikipedia.org/w/index.php?title=Huanan_Seafood_Wholesale_Market&oldid=950281895
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020. https:// doi.org/10.1038/s41586-020-2008-3.
S.R. Weiss, S. Navas-Martin, Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus, Microbiol. Mol. Biol. Rev. 69 (4) (2005) 635–664.
A.R. Fehr, S. Perlman, Coronaviruses: an overview of their replication and pathogenesis, Methods Mol. Biol. 1282 (2015) 1–23.
L. Zhao, et al., Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology, Cell Host Microbe 11 (6) (2012) 607–616.
Z. Song, et al., From SARS to MERS, thrusting coronaviruses into the spotlight, Viruses 11 (1) (2019) 59.
The Harvard Gazette, Coronavirus Cases Hit 17,400 and Are Likely to Surge, (2020) https://news.harvard.edu/gazette/story/2020/02/as-confirmed-cases-ofcoronavirus- surge-path-grows-uncertain/.
Z. Zhao, et al., Moderate mutation rate in the SARS coronavirus genome and its implications, BMC Evol. Biol. 4 (2004) 21.
P.C. Woo, S.K. Lau, K.Y. Yuen, Infectious diseases emerging from Chinese wetmarkets: zoonotic origins of severe respiratory viral infections, Curr. Opin. Infect. Dis. 19 (5) (2006) 401–407.
P.C. Woo, et al., Coronavirus diversity, phylogeny and interspecies jumping, Exp. Biol. Med. 234 (10) (2009) 1117–1127.
P.C. Woo, et al., Comparative analysis of 22 coronavirus HKU1 genomes reveals a novel genotype and evidence of natural recombination in coronavirus HKU1, J. Virol. 80 (14) (2006) 7136–7145.
Wu D, Zou S, Bai T, Li J, Zhao X, Yang L, et al. Poultry farms as a source of avian influenza a (H7N9) virus reassortment and human infection. Sci Rep. 2015;5:7630.
Tang X, Wu C, Li X, Song Y, Yao X, Wu X, et al. On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev. 2020. https://doi.org/10. 1093/nsr/nwaa036.
Yin Y,Wunderink RG.MERS, SARS and other coronaviruses as causes of pneumonia. Respirology 2018;23:130–7 http://doi.org/10.1111/resp.13196.
Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 2020. https://doi.org/10.1002/jmv.25681.
Enjuanes L, Zuniga S, Castano-Rodriguez C, Gutierrez-Alvarez J, Canton J, Sola I. Molecular basis of coronavirus virulence and vaccine development. Adv Virus Res 2016; 96:245–86 http://doi.org/10.1016/bs.aivir.2016.08.003.
Ding Y, Wang H, Shen H, Li Z, Geng J, Han H, et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol 2003;200:282–9 http://doi.org/10.1002/path.1440.
de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 2016;14:523–34 http://doi. org/10.1038/nrmicro.2016.81.
D.S. Hui, E. IA, T.A. Madani, F. Ntoumi, R. Kock, O. Dar, et al., The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China, Int. J. Infect. Dis. 91 (2020) 264–266.
R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, et al., Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet 395 (10224) (2020) 565–574, https://doi.org/10.1016/S0140-6736(20)30251-8. [20] Y. Wan, J. Shang, R. Graham, R.S. Baric, F. Li, Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS, J. Virol. (2020), https://doi.org/10.1128/JVI.00127-20.
L.L. Ren, Y.M. Wang, Z.Q. Wu, Z.C. Xiang, L. Guo, T. Xu, et al., Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study, Chinese Med J (2020), https://doi.org/10.1097/CM9.0000000000000722.
J. Cui, F. Li, Z.L. Shi, Origin and evolution of pathogenic coronaviruses, Nat. Rev. Microbiol. 17 (2019) 181–192.
N. Zhu, D. Zhang, W. Wang, X. Li, B. Yang, J. Song, et al., A novel coronavirus from patients with pneumonia in China, N. Engl. J. Med. 382 (2019) 727–733, https:// doi.org/10.1056/NEJMoa2001017 2020.
Paules CI, Marston HD, Fauci AS. Coronavirus infections---more than just the common cold. JAMA 2020. doi: 10.1001/jama.2020.0757.
de Wilde AH, Snijder EJ, Kikkert M, van Hemert MJ. Host factors in coronavirus replication. Curr Top Microbiol Immunol 2018;419:1-42.
Millet JK, Whittaker GR. Host cell proteases: critical determinants of coronavirus tropism and pathogenesis. Virus Res. 2015;202:120–34.
Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, Bates P. Inhibitors of cathepsin L prevent severe acute respiratory sÃndrome coronavirus entry. P Natl Acad Sci USA. 2005;102(33):11876–81.
Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005;79(23): 14614–21.
Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J Virol. 2020. https://doi.org/10.1128/JVI.00127-20.
Li W, Moore MJ, Vasilieva N, et al. Angiotensin-con¬verting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426:450-4.
Qian Z, Travanty EA, Oko L, et al. Innate immune re¬sponse of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Am J Respir Cell Mol Biol 2013;48:742-8.
Lu G, Hu Y, Wang Q, et al. Molecular basis of bind¬ing between novel human coronavirus MERS-CoV and its receptor CD26. Nature 2013;500:227-31.
Raj VS, Mou H, Smits SL, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 2013;495:251-4.
Knipe DM, Howley PM. Fields’ Virology. vol 1. 5th ed. Wolters Kluwer, 2007.
Tortorici MA, Veesler D. Structural insights into coronavirus entry. Adv Virus Res. 2019;105:93–116.
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020. https://doi.org/10.1038/s41586-020-2012-7.
Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci Chin Life Sci. 2020; https://doi. org/10.1007/s11427-020-1637-5.
Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020. https://doi.org/10.1038/s41564-020-0688-y.
Song W, Gui M, Wang X, Xiang Y. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog. 2018;14(8):e1007236.
Zhang N, Jiang S, Du L. Current advancements and potential strategies in the development of MERS-CoV vaccines. Expert Rev Vaccines. 2014;13(6):761–74.
Xia S, Zhu Y, Liu M, Lan Q, Xu W, Wu Y, et al. Fusion mechanism of 2019- nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell Mol Immunol. 2020. https://doi.org/10.1038/s41423-020-0374-2.
Yu F, Du L, Ojcius DM, Pan C, Jiang S. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes Infect. 2020. https://doi.org/10.1016/j. micinf.2020.01.003.
Sawicki SG, Sawicki DL. Coronavirus transcription: a perspective. Curr Top Microbiol Immunol. 2005;287:31–55.
Hussain S, Pan J, Chen Y, Yang Y, Xu J, Peng Y, et al. Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus. J Virol. 2005;79(9):5288–95.
Perrier A, Bonnin A, Desmarets L, Danneels A, Goffard A, Rouille Y, et al. The C-terminal domain of the MERS coronavirus M protein contains a trans- Golgi network localization signal. J Biol Chem. 2019;294(39):14406–21.
20200331-sitrep-71-covid-19.pdf [Internet]. [cited 2020 Apr 12]. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200331-sitrep-71-covid-19.pdf?sfvrsn=4360e92b_8
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507e13. https://doi.org/10.1016/S0140- 6736(20)30211-7.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. J Am Med Assoc 2020 Feb 7. https://doi.org/10.1001/jama.2020.1585.
Guan WJ, Ni ZY, Hu Y, Laing WH, Ou CQ, He JX, et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv 2020 Feb 9. https: //doi.org/10.1101/2020.02.06.20020974. preprint. 12. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507e13. https://doi.org/10.1016/S0140- 6736(20)30211-7.
Yang Y, Lu Q, Liu M, Wang Y, Zhang A, Jalali N, et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv 2020 Feb 11. https: //doi.org/10.1101/2020.02.10.20021675.
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus disease (COVID-19) e China. China CDC Weekly; 2020.
Chen H, Guo J,Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review ofmedical records. Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)30360-3.
Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020;395:514e23. https: //doi.org/10.1016/S0140-6736(20)30154-9.
Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020. https://doi.org/10.1056/NEJMc2001468.
Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. J Hosp Infect. 2020 Feb 6. pii: S0195–6701(20)30046–3.
World Health Organization. Situation reports. Available at: https:// www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Accessed 22 Feb 2020.
Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020. https://doi.org/10.1056/NEJMc2001737.
Liu T, Hu J, Kang M, Lin L, Zhong H, Xiao J, et al. Transmission dynamics of 2019 novel coronavirus (2019-nCoV). 2020; doi: https://doi.org/10.1101/2020. 01.25.919787.
Coronavirus Outbreak. Available at: https://www.worldometers. info/coronavirus/. Accessed 23 Feb 2020.
Cheng ZJ, Shan J. 2019 novel coronavirus: where we are and what we know. Infection. 2020:1–9. https://doi.org/10.1007/s15010-020- 01401-y.
Y. Wan, J. Shang, R. Graham, R.S. Baric, F. Li, Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS, J. Virol. (2020), https://doi.org/10.1128/JVI.00127-20.
W. Ji, W. Wang, X. Zhao, J. Zai, X. Li, Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human, J. Med. Virol. 92 (4) (2020) 433–440, https://doi. org/10.1002/jmv.25682.
M. Bassetti, A. Vena, D. Roberto Giacobbe, The Novel Chinese Coronavirus (2019- nCoV) Infections: challenges for fighting the storm, Eur. J. Clin. Invest. (2020) e13209, , https://doi.org/10.1111/eci.13209.
National Health Commission of People’s Republic of China. Pneumonia diagnosis and treatment of 2019-nCoV infection from Chinese NHC and CDC 2020. 2020. http://www.nhc.gov.cn/xcs/zhengcwj/202001/4294563ed35 b43209b31739bd0785e67/files/7a9309111267475a99d4306962c8bf78.pdf. Accessed 1 Feb 2020.
National Health Commission of People’s Republic of China. Prevent guideline of 2019-nCoV. 2020. http://www.nhc.gov.cn/xcs/yqfkdt/202001/ bc661e49b5bc487dba182f5c49ac445b.shtml. Accessed 1 Feb 2020.
Zhang H, Kang Z, Gong H, Xu D, Wang J, Li Z, et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv. 2020; doi: https://doi.org/10.1101/2020. 01.30.927806.
Control Ecfdpa. Outbreak of acute respiratory syndrome associated with a novel coronavirus, Wuhan, China; first update, https://www.ecdc.europa.eu/sites/default/ files/documents/Risk-assessment-pneumonia-Wuhan-China-22-Jan-2020.pdf; 2020 [accessed 2020-2-5].
American Association of Blood Banks. Update: impact of 2019 novel coronavirus and blood safety, http://www.aabb.org/advocacy/regulatorygovernment/Documents/ Impact-of-2019-Novel-Coronavirus-on-Blood-Donation.pdf; 2020 [accessed 2020- 2-5].
Bai Y, Yao L, Wei T, Tian F, Jih DY, Chen L, et al. Presumed asymptomatic carrier transmission of COVID-19. J Am Med Assoc 2020 Feb 21. https://doi.org/10.1001/jama.2020.2565.
Chang Xu H, Rebaza A, Sharma L, Dela Cruz CS. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med 2020 Feb 13. https://doi.org/10.1016/S2213- 2600(20)30066-7. pii: S2213-2600(20)30066-30067.
Chan Jasper FW, Yuan SF, Kok KH et al (2020) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating personto- person transmission: a study of a family cluster. Lancet. https ://doi. org/10.1016/s0140 -6736(20)30154 -9.
Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019- nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7(1):4.
Day M. Covid-19: four fifths of cases are asymptomatic, China figures indicate. BMJ. 2020 Apr 2;369:m1375. doi: 10.1136/bmj.m1375. PubMed PMID: 32241884.
Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epide¬miological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descrip¬tive study. Lancet Infect Dis 2013;13:752-61.
Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003; 348(20):1986–94.
https://www.who.int/influenza/surveillance_monitoring/bod/WHO-INFLUENZA-MortalityEstimate_sp.pdf.
Chen F, Liu ZS, Zhang FR, et al. First case of severe childhood novel coronavirus pneumonia in China. Zhonghua Er Ke Za Zhi. 2020;58:E005.
Zeng LK, Tao XW, YuanWH,Wang J, Liu X, Liu ZS. First case of neonate infected with novel coronavirus pneumonia in China. Zhonghua Er Ke Za Zhi. 2020;58:E009.
Wong CK, Lam CW, Wu AK, et al. Plasma inflam¬matory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 2004;136:95-103.
Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology. 2020;200230. https://doi.org/10.1148/radiol.2020200230.
J. Lei, J. Li, X. Li, X. Qi, CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia, Radiology (2020) 200236, https://doi.org/10.1148/radiol. 2020200236.
Lei J, Li J, Li X, Qi X. CT Imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology 2020 Jan 31:200236. https: //doi.org/10.1148/radiol.2020200236.
Pan Y, Guan H. Imaging changes in patients with 2019-nCov. Eur Radiol 2020 Feb 6. https://doi.org/10.1007/s00330-020-06713-z.
Kanne JP. Chest CT findings in 2019 novel coronavirus (2019- nCoV) infections from Wuhan, China: key points for the radiologist. Radiology 2020 Feb 4:200241. https: //doi.org/10.1148/radiol.2020200241.
Duan YN, Qin J. Pre- and posttreatment chest CT findings: 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology 2020 Feb 12:200323. https://doi.org/10.1148/radiol.2020200323.
The -nCo, V.O.J.F.E.I.T. L. Qun, An outbreak of NCIP (2019-nCoV) infection in China — wuhan, Hubei province, 2019−2020, China CDC Weekly 2 (5) (2020) 79–80.
Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92(4):401–2.
Hung IF, Cheng VC, Wu AK et al (2004) Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis 10:1550–1557.
Holshue ML, DeBolt C, Lindquis S et al (2020) First case of 2019 novel coronavirus in the United States. N Engl J Med. https ://doi.org/10.1056/ nejmo a2001 191.
Zumla A, Chan JF, Azhar EI, Hui DS, Yuen KY. Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov. 2016;15(5):327–47.
Li H, Wang YM, Xu JY, Cao B. Potential antiviral therapeutics for 2019 Novel Coronavirus. Chin J Tuberc Respir Dis. 2020;43(0):E002.
Arabi YM, Mandourah Y, Al-Hameed F et al (2018) Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome. Am J Respir Crit Care Med 197:757–767.
WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Jan 11, 2020. https :// www.who.int/inter nal-publi catio ns-detai l/clini calma nagem ent-of-sever e-acute -respi rator y-infec tion-when-novel coron aviru s-(ncov)-infec tion-issuspe cted. Accessed 30 Jan 2020.
Lee DT, Wing YK, Leung HC, Sung JJ, Ng YK, Yiu GC, et al. Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study. Clin Infect Dis 2004;39:1247e9.
Xiao JZ, Ma L, Gao J, Yang ZJ, Xing XY, Zhao HC, et al. Glucocorticoid- induceddiabetes insevereacute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy. Zhonghua Nei Ke Za Zhi 2004;43:179e82.
Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395:473–5.
Zhao JP, Hu Y, Du RH, et al. Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E007.
Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. J Med Virol 2020;92:424e32. https://doi.org/10.1002/jmv.25685.
Agostini ML, Andres EL, Sims AC, Graham RL, Sheahan TP, Lu X, et al. Coronavirus susceptibility to the antiviral remdesivir (gs-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio. 2018; 9(2):e00221–18. https://doi.org/10.1128/mBio.00221-18.
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020 Feb 4. https: //doi.org/10.1038/s41422-020-0282-0.
https: // Clinicaltrials.gov/ct2/show/NCT04252664.
https: //linicaltrials.gov/ct2/show/NCT04257656.
Ko WC, Rolain JM, Lee NY, Chen PL, Huang CT, Lee PI, et al. Arguments in favor of remdesivir for treating SARS-CoV-2 infections. Int J Antimicrob Agents 2020 Mar 6. https: //doi.org/10.1016/j.ijantimicag.2020.105933.
Aguiar ACC, Murce E, Cortopassi WA, Pimentel AS, Almeida M, Barros DCS, et al. Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity. Int J Parasitol Drugs Drug Resist. 2018;8(3):459–64.
Colson P, Rolain JM, Raoult D. Chloroquine for the 2019 novel coronavirus. Int J Antimicrob Agents 2020 Feb 17. https: //doi.org/10.1016/j.ijantimicag.2020.105923.
Multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia. [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi 2020 Feb 20;43(0):E019. https://doi.org/10.3760/cma.j.issn.1001-0939.2020.0019.
Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today’s diseases? Lancet Infect Dis. 2003;3(11):722–7.
Golden EB, Cho HY, Hofman FM, Louie SG, Schonthal AH, Chen TC. Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors. Neurosurg Focus. 2015;38(3):E12.
Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005;2:69.
Vincent JM, Marion K, van Doremalen N et al (2020) A novel coronavirus emerging in China—key questions for impact assessment. N Engl J Med. https ://doi.org/10.1056/nejmp 20009 29.
Cvetkovic RS, Goa KL. Lopinavir/ritonavir: a review of its use in the management of HIV infection. Drugs. 2003;63(8):769–802.
Arabi YM, Asiri AY, Assiri AM, Aziz Jokhdar HA, Alothman A, Balkhy HH, et al. Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial. Trials. 2020;21(1):8.
Chu CM, Cheng VC, Hung IF, Wong MM, Chan KH, Chan KS, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59(3):252–6.
Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ, et al. Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J Korean Med Sci. 2020;35(6):e79.
Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infec¬tion is suspected. Available from www.who.int/ publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavi¬rus-(ncov)-infection-is-suspected (Accessed January 31, 2020).
Chen L, Xiong J, Bao L, Shi Y. Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis. 2020. https://doi.org/10.1016/s1473- 3099(20)30141-9.
Li J, Li J, Xie X, et al. Game consumption and the 2019 novel coronavirus. Lancet Infect Dis. 2020. https://doi.org/10.1016/ S1473-3099(20)30063-3.
Vincent JM, Marion K, van Doremalen N et al (2020) A novel coronavirus emerging in China—key questions for impact assessment. N Engl J Med. https ://doi.org/10.1056/nejmp 20009 29.
Wenjie T, et al., A novel coronavirus genome identified in a cluster of pneumonia cases — wuhan, China 2019−2020, China CDC Weekly 2 (4) (2020) 61–62.
National Health Commission of People’s Republic of China. Pneumonia infected with novel coronavirus is included in the management of legal infectious diseases. 2020. http://www.nhc.gov.cn/jkj/s7915/202001/e4e2d5e6 f01147e0a8df3f6701d49f33.shtml. Accessed 31 Jan 2020.
National Health Commission of People’s Republic of China. Notice on further prevention and control of pneumonia caused by novel coronavirus infection in rural areas. 2020. http://www.nhc.gov.cn/jkj/s3578/202001/f8d45 f6af1d24ef18151c1d91cf8a028.shtml. Accessed 31 Jan 2020.
National Health Commission of People’s Republic of China. Notice on prevention and control of novel coronavirus infection pneumonia in the elderly people. 2020. http://www.nhc.gov.cn/lljks/tggg/202001/96e82ba8a14 d41b283da990d39771493.shtml. Accessed 31 Jan 2020.
National Health Commission of People’s Republic of China. Notice on printing and distributing the work plan for prevention and control of pneumonia caused by novel coronavirus infection in the near future. 2020. http://www.nhc.gov.cn/tigs/s7848/202001/808bbf75e5ce415aa19f74 c78ddc653f.shtml. Accessed 31 Jan 2020.
Wei Q, Ren Z. Disinfection measures for pneumonia foci infected by novel coronavirus in 2019. Chin J Disinfect. 2020;37:59–62. 51. World Health Organization. International clinical trials registry platform. 2020. https://apps.who.int/trialsearch/default.aspx. Accessed 23 Feb 2020. 52. Chinese Clinical Trial Registry.
Ou F, Wu H, Yang Y, Tan W, Zhang J, Gu J. Countermeasures for rapid spread of new coronavirus pneumonia in Wuhan. Chin General Pract Nurs. 2020. http://kns.cnki.net/kcms/detail/14.1349.R.20200131.1319.002.html. Acessed 2 Feb 2020.
World Health Organization. Coronavirus disease [COVID-19] Technical Guidance: Infection Prevention and Control. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus- 2019/technical-guidance/infection-prevention-and-control. Accessed 20 Feb 2020.
WHO. Advice on the use of masks in the community, during home care and in health care settings in the context of the novel coronavirus 2019- nCoV outbreak (Interim guidance). 2020. HO/nCov/IPC_Masks/2020. Accessed 3 Feb 2020.
Interim infection prevention and control recommendations for patients with known or patients under investigation for 2019 novel coronavirus (2019-nCoV) in a healthcare setting. https ://www.cdc.gov/coron aviru s/2019-nCoV/hcp/infec tion-contr ol.html. Accessed 30 Jan 2020.
Li Wenliang. In: Wikipedia [Internet]. 2020 [cited 2020 Apr 11]. Available from: https://en.wikipedia.org/w/index.php?title=Li_Wenliang&oldid=949849782
Chang D, Xu H, Rebaza A, Sharma L, Dela Cruz CS. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med. 2020. https://doi.org/10.1016/S2213-2600(20)30066- 7.
National Health Commission of People’s Republic of China. Guidelines for public protection against novel coronavirus infection. 2020. http://www.nhc.gov.cn/jkj/s7915/202001/bc661e49b5bc487dba182f5c49ac445b.shtml. Accessed 31 Jan 2020.
Este artÃculo está licenciado bajo la licencia Creative Commons Reconocimiento-NoComercial 4.0 Internacional .
